Sunflower Pharmaceutical GroupLtd Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yi Guan

Chief Executive Officer (CEO)

CN¥4.8m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	5.8yrs
Participación del CEO	n/a
Permanencia media de la dirección	2.9yrs
Promedio de permanencia en la Junta Directiva	3.4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Yi Guan (42 yo)

5.8yrs

Permanencia

CN¥4,800,000

Compensación

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Yi Guan	GM & Non-Independent Director	5.8yrs	CN¥4.80m	sin datos
Chunhong Wu	Financial Manager	2.9yrs	CN¥774.90k	sin datos
Guangguang Zhou	Board Secretary	2.8yrs	CN¥436.70k	sin datos
Liang Chen	Deputy General Manager	2.9yrs	CN¥3.06m	sin datos
Jin Ming Lin	Deputy General Manager	4.8yrs	CN¥786.00k	sin datos
Xin Ma	Deputy General Manager	2.9yrs	CN¥1.36m	sin datos
Yang Hai	Deputy General Manager	2.9yrs	CN¥1.41m	sin datos

2.9yrs

Permanencia media

43yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 002737 se considera experimentado (2.9 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Yi Guan	GM & Non-Independent Director	7.2yrs	CN¥4.80m	sin datos
Yanling Guan	Non-Independent Director	10.7yrs	CN¥1.18m	sin datos
Jingshang Ren	Non-Independent Director	7.2yrs	CN¥50.00k	sin datos
Yan He	Non-Employee Supervisor	7.2yrs	sin datos	sin datos
Chunyan Na	Supervisor	4.1yrs	sin datos	sin datos
Yuxiu Guan	Chairman	5.8yrs	CN¥1.20m	sin datos
Fen Lan	Chairman of the Supervisory Board	2.7yrs	sin datos	sin datos
Jianzhong Zhou	Non-Independent Director	less than a year	sin datos	sin datos
Yang Yang	Non-Independent Director	less than a year	sin datos	sin datos
Jiajun Miao	Independent Director	less than a year	sin datos	sin datos
Ying Zhang	Independent Director	less than a year	sin datos	sin datos
Yan Zhao	Independent director	less than a year	sin datos	sin datos

3.4yrs

Permanencia media

46yo

Promedio de edad

Junta con experiencia: La junta directiva de 002737 se considera experimentada (3.4 años de antigüedad promedio).

Sunflower Pharmaceutical GroupLtd Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd Announces Board Appointments

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 30, 2024

High number of new directors

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 13, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.37 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Sunflower Pharmaceutical Group Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.40 in 2Q 2023)

Now 22% overvalued

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd to Report First Half, 2024 Results on Aug 28, 2024

Sunflower Pharmaceutical Group Co.,Ltd Announces Board Appointments

Investor sentiment deteriorates as stock falls 16%

Dividend increased to CN¥1.50

Sunflower Pharmaceutical Group Co.,Ltd Announces Final Cash Dividend (Tax Included) (A Shares) for the Year 2023, Payable on 14 June 2024

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 30, 2024

Sunflower Pharmaceutical Group Co.,Ltd Announces Profit Distribution Proposal for 2023

First quarter 2024 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 1Q 2023)

Sunflower Pharmaceutical Group Co.,Ltd to Report Q1, 2024 Results on Apr 26, 2024

Sunflower Pharmaceutical Group Co.,Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.18 in 3Q 2022)

Sunflower Pharmaceutical Group Co.,Ltd to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.40 (vs CN¥0.32 in 2Q 2022)

Sunflower Pharmaceutical Group Co.,Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 7, 2023

Full year 2022 earnings released: EPS: CN¥1.48 (vs CN¥1.21 in FY 2021)

Now 20% undervalued

Now 22% undervalued after recent price drop

Now 21% undervalued

Now 21% undervalued

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 21% undervalued

Now 21% undervalued

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in 3Q 2021)

Investor sentiment improved over the past week

Now 21% undervalued

High number of new directors

Now 20% undervalued

Second quarter 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.14 in 2Q 2021)

Sunflower Pharmaceutical Group Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 02 June 2022

Sunflower Pharmaceutical Group Co.,Ltd Approves 2021 Profit Distribution Plan

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥1.21 (vs CN¥1.00 in FY 2020)

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 13, 2022

Sunflower Pharmaceutical Group Co.,Ltd Proposes Final Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.14 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.15 in 2Q 2020)

Investor sentiment improved over the past week

Sunflower Pharmaceutical Group Co.,Ltd Approves Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.00 (vs CN¥0.97 in FY 2019)

Sunflower Pharmaceutical Group Co.,Ltd to Report Fiscal Year 2020 Results on Apr 21, 2021

New 90-day low: CN¥12.98

New 90-day low: CN¥14.03

New 90-day low: CN¥14.53

Third quarter earnings released

Sunflower Pharmaceutical Group Co.,Ltd Announces Executive Appointments

New 90-day high - CN¥16.50

Earnings released

Sunflower Pharmaceutical Group Co.,Ltd to Report First Half, 2020 Results on Aug 26, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad